Does GOLIMUMAB Cause Hypertransaminasaemia? 36 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Hypertransaminasaemia have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.1% of all adverse event reports for GOLIMUMAB.
36
Reports of Hypertransaminasaemia with GOLIMUMAB
0.1%
of all GOLIMUMAB reports
12
Deaths
17
Hospitalizations
How Dangerous Is Hypertransaminasaemia From GOLIMUMAB?
Of the 36 reports, 12 (33.3%) resulted in death, 17 (47.2%) required hospitalization, and 30 (83.3%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which GOLIMUMAB Alternatives Have Lower Hypertransaminasaemia Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN